# FDA 483 - Belmar Labs, LLC - May 20, 2026

Source: https://www.keypedia.com/records/483/belmar-labs-llc/47190be9-5646-4a30-b396-02bcce746bc7

> FDA 483 for Belmar Labs, LLC on May 20, 2026. Product: drugs. Access full analysis and detailed observations.

---

## Details

- Record Type: 483
- Company Name: Belmar Labs, LLC
- Inspection Date: 2026-05-20
- Product Type: drugs
- Office Name: FDA District Office — Denver, Colorado
- Summary: Belmar Labs, LLC, a contract testing facility in Golden, CO, received a Form 483 from the FDA following an inspection. The report details significant quality control deficiencies, including inadequate investigations into recurring incubation process failures and a failure to ensure the effectiveness of corrective actions. Additionally, the firm was cited for using unverified reference standards and for not conducting identity testing on incoming materials, raising concerns about the reliability of their testing operations.

## Related Officers

- [company_representative](https://www.keypedia.com/people/nelson-n-ayangho/917cb8ea-904d-41a1-b522-2351d3cb1f74)

Company: https://www.keypedia.com/companies/belmar-labs-llc/36a09392-2d28-4154-9530-2e1f5485cd2f

Office: https://www.keypedia.com/offices/fda-district-office-denver-colorado/1670d160-cbfd-48fd-b9c1-fbba4631fcb0